BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease

This publication has 14 references indexed in Scilit:

• Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease
  Annals of Oncology, 1995
• Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.
  Journal of Clinical Oncology, 1994
• Prognosis of High Dose Chemotherapy/Autologous Bone Marrow Transplantation Candidates not Receiving This Treatment after Failure of Primary Therapy of Hodgkin's Disease
  Leukemia & Lymphoma, 1994
• Dose-escalation study for the treatment of Hodgkin's disease
  Annals of Hematology, 1993
• Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
  New England Journal of Medicine, 1992
• British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease – long term results
  British Journal of Cancer, 1991
• ChlVPP combination chemotherapy for Hodgkin's disease: long term results
  British Journal of Cancer, 1990
• A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.
  Journal of Clinical Oncology, 1983
• Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
  Cancer, 1975
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958